Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Tailored cell sheet engineering using microstereolithography and electrochemical cell transfer.

Kobayashi Y, Cordonier CEJ, Noda Y, Nagase F, Enomoto J, Kageyama T, Honma H, Maruo S, Fukuda J.

Sci Rep. 2019 Jul 18;9(1):10415. doi: 10.1038/s41598-019-46801-9.

2.

Factors associated with positive and negative recommendations for cancer and non-cancer drugs for rare diseases in Canada.

Nagase FNI, Stafinski T, Sun J, Jhangri G, Menon D.

Orphanet J Rare Dis. 2019 Jun 7;14(1):127. doi: 10.1186/s13023-019-1104-7.

3.

Crosstalk between second messengers predicts the motility of the growth cone.

Kobayashi T, Nagase F, Hotta K, Oka K.

Sci Rep. 2013 Nov 1;3:3118. doi: 10.1038/srep03118.

4.

Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species.

Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, Isobe K, Nagase F.

J Cell Biochem. 2009 Oct 15;108(3):716-25. doi: 10.1002/jcb.22308.

PMID:
19693771
5.

High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.

Hara T, Ogasawara N, Akimoto H, Takikawa O, Hiramatsu R, Kawabe T, Isobe K, Nagase F.

Immunol Lett. 2008 Feb 15;116(1):95-102. doi: 10.1016/j.imlet.2007.11.016. Epub 2007 Dec 26.

PMID:
18179826
6.

Diazotization of kynurenine by acidified nitrite secreted from indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells.

Hara T, Yamakura F, Takikawa O, Hiramatsu R, Kawabe T, Isobe K, Nagase F.

J Immunol Methods. 2008 Mar 20;332(1-2):162-9. Epub 2007 Dec 17.

PMID:
18158157
7.
8.

Binding activity of H-Ras is necessary for in vivo inhibition of ASK1 activity.

Du J, Cai SH, Shi Z, Nagase F.

Cell Res. 2004 Apr;14(2):148-54.

10.

Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal.

Du J, Cai S, Suzuki H, Akhand AA, Ma X, Takagi Y, Miyata T, Nakashima I, Nagase F.

J Cell Biochem. 2003 Apr 15;88(6):1235-46.

PMID:
12647305
11.

Redox-linked cell surface-oriented signaling for T-cell death.

Akhand AA, Du J, Liu W, Hossain K, Miyata T, Nagase F, Kato M, Suzuki H, Nakashima I.

Antioxid Redox Signal. 2002 Jun;4(3):445-54. Review.

PMID:
12215211
12.

Menadione biphasically controls JNK-linked cell death in leukemia Jurkat T cells.

Ma X, Du J, Nakashima I, Nagase F.

Antioxid Redox Signal. 2002 Jun;4(3):371-8.

PMID:
12215205
13.

Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process.

Du J, Suzuki H, Nagase F, Akhand AA, Ma XY, Yokoyama T, Miyata T, Nakashima I.

Free Radic Biol Med. 2001 Aug 15;31(4):469-78.

PMID:
11498280
14.

Midgut malrotation in adulthood.

Kanazawa T, Kasugai K, Miyata M, Miyashita M, Mizuno M, Nagase F, Hibino K, Muramatu W, Hayashi K, Aihara M, Yoshida T, Utsumi K, Nitta M.

Intern Med. 2000 Aug;39(8):626-31.

15.

Mercuric chloride stimulates distinct signal transduction pathway for DNA synthesis in a T-cell line, CTLL-2.

Du J, Suzuki H, Nagase F, Akhand AA, Yokoyama T, Nakashima I.

J Cell Biochem. 2000 Jun 6;78(3):500-8.

PMID:
10861847
16.

[A case of amebic colitis with liver abscess].

Aihara M, Yoshida T, Hibino K, Takagi R, Mizuno M, Nagase F, Miyata M, Tanaka A, Kasugai K, Tounai M, Utsumi K, Mizuno H, Nitta M.

Nihon Shokakibyo Gakkai Zasshi. 2000 Mar;97(3):366-8. Japanese. No abstract available.

PMID:
10741165
17.

Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase.

Du J, Suzuki H, Nagase F, Akhand AA, Yokoyama T, Miyata T, Kurokawa K, Nakashima I.

J Cell Biochem. 2000 Mar;77(2):333-44.

PMID:
10723098
18.

Induction of apoptosis and tyrosine phosphorylation of cellular proteins in T cells and non-T cells by stimulation with concanavalin A.

Nagase F, Abo T, Hiramatsu K, Suzuki S, Du J, Nakashima I.

Microbiol Immunol. 1998;42(8):567-74.

19.

Age differences of psychiatric inpatients presenting with physical complications.

Nagatomo I, Nagase F, Shimojima K, Nomaguchi M, Takigawa M.

Psychiatry Clin Neurosci. 1996 Oct;50(5):243-6.

PMID:
9201784
20.

Relationships between convulsive seizures and serum and brain concentrations of phenobarbital and zonisamide in mutant inbred strain EL mouse.

Nagatomo I, Akasaki Y, Nagase F, Nomaguchi M, Takigawa M.

Brain Res. 1996 Aug 26;731(1-2):190-8.

PMID:
8883869
21.
24.

Characterization of the immunoregulatory action of saikosaponin-d.

Kato M, Pu MY, Isobe K, Iwamoto T, Nagase F, Lwin T, Zhang YH, Hattori T, Yanagita N, Nakashima I.

Cell Immunol. 1994 Nov;159(1):15-25.

PMID:
7954839
25.

Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes.

Zhang YH, Isobe K, Nagase F, Lwin T, Kato M, Hamaguchi M, Yokochi T, Nakashima I.

Immunology. 1993 Aug;79(4):528-34.

26.

A possible site of in vivo action of cyclosporin A for transplantation immunity: comparative study with cyclophosphamide.

Hasegawa Y, Isobe K, Nagase F, Shimokata K, Nakashima I.

Immunobiology. 1991 Nov;183(5):408-17.

PMID:
1786989
27.

Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.

Iwamoto T, Pu M, Ito M, Takahashi M, Isobe K, Nagase F, Kawashima K, Ichihara M, Nakashima I.

Eur J Immunol. 1991 Aug;21(8):1809-14.

PMID:
1868872
28.

Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant.

Ding LN, Yoshida T, Isobe K, Rahman SM, Nagase F, Yokochi T, Kawashima K, Nakashima I.

Jpn J Cancer Res. 1991 Jul;82(7):841-7.

29.

Allotype-linked immune response genes: roles in network control of the immune system.

Nakashima I, Isobe K, Yoshida T, Iwamoto T, Nagase F, Zhang YH, Pu M, Lwin T.

Exp Clin Immunogenet. 1991;8(3):121-39. Review.

PMID:
1799457
30.

Modulation by glycyrrhizin of the cell-surface expression of H-2 class I antigens on murine tumour cell lines and normal cell populations.

Zhang YH, Yoshida T, Isobe K, Rahman SM, Nagase F, Ding L, Nakashima I.

Immunology. 1990 Jul;70(3):405-10.

31.

Demonstration of lipid A-binding proteins on murine lymphoma cells using R-mutant gram-negative bacteria as a detector.

Nakashima I, Kubota T, Zhang Y, Yoshida T, Inagi R, Isobe K, Nagase F, Ohta M, Kato N, Yokochi T.

APMIS. 1990 Jan;98(1):87-94.

PMID:
2405889
32.

Cytotoxic T lymphocyte recognition of the H-2-erbB hybrid gene product lacking the complete H-2 domain structure.

Ding L, Isobe K, Iwamoto T, Yoshida T, Nagase F, Kawashima K, Nakashima I.

Int Immunol. 1990;2(1):91-7.

PMID:
1708275
34.

Further evidence for H-2-unrestricted induction of minor histocompatibility antigens-specific T cell immunity in vivo.

Mizoguchi K, Isobe K, Yoshida T, Iwamoto T, Hasegawa T, Ding L, Rahman SM, Miyata T, Nagase F, Shimokata K, et al.

Immunol Lett. 1988 Sep;19(1):41-7.

PMID:
3263947
35.

Augmentation by Corynebacterium liquefaciens of erythrocyte surface H-2 expression and alloimmunogenicity for antibody responses.

Yoshida T, Nakashima I, Yokochi T, Mizoguchi K, Ding RN, Kato N, Isobe K, Nagase F, Ando K, Iwamoto T.

Transplantation. 1988 Aug;46(2):261-6.

PMID:
3261464
36.

Genetic and stimulator cell requirements for generation and activation of minor histocompatibility antigen-specific memory cytotoxic T-lymphocyte precursors.

Ando KI, Isobe KI, Hasegawa T, Iwamoto T, Ding RN, Rahman J, Muro Y, Yoshida T, Nagase F, Kawashima K, et al.

Immunology. 1988 Aug;64(4):661-7.

37.

Dynamics of cytotoxic T lymphocyte precursors in vivo assessed by change in the radiation sensitivity. Evidence for development of radiation-sensitive memory cells without clonal expansion.

Hasegawa Y, Nakashima I, Ando K, Mizoguchi K, Nagase F, Isobe K, Kawashima K, Shimokata K, Yoshida T, Iwamoto T.

Scand J Immunol. 1988 Jul;28(1):43-53.

PMID:
2969613
38.

Biphasic radiation-sensitivity of the transplantation immunity for rejection of an allogeneic ascites tumor.

Hasegawa Y, Nakashima I, Mizoguchi K, Nagase F, Isobe K, Shimokata K, Kawashima K, Ando K, Yoshida T, Iwamoto T, et al.

Immunobiology. 1988 May;177(2):120-33.

PMID:
3042613
39.

Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.

Ando K, Nakashima I, Nagase F, Isobe K, Kawashima K, Hasegawa Y, Yoshida T, Iwamoto T, Hasegawa T, Muro Y, et al.

J Immunol. 1988 Feb 1;140(3):723-9.

PMID:
2448374
40.

Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions.

Kuwana Y, Asakura Y, Utsunomiya N, Nakanishi M, Arata Y, Itoh S, Nagase F, Kurosawa Y.

Biochem Biophys Res Commun. 1987 Dec 31;149(3):960-8.

PMID:
3122749
41.

Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone.

Nagase F, Rahman SM, Yokochi T, Kawashima K, Isobe K, Yoshida T, Nagura E, Nakashima I.

Cancer Res. 1987 Dec 15;47(24 Pt 1):6494-9.

42.

L1210 leukemia regression in non-immunosuppressed mice with therapeutic transfer of immune spleen cells--therapeutic adoptive transfer against L1210 leukemia.

Kawashima K, Nagura E, Nagase F, Kumazawa T, Nakashima I, Yamada K.

Nihon Ketsueki Gakkai Zasshi. 1987 Sep;50(6):1174-82. No abstract available.

PMID:
3687342
43.

Production of the constant domain of murine T-cell receptor beta-chain in Escherichia coli.

Kuwana Y, Itoh S, Nagase F, Nakashima I, Kurosawa Y.

FEBS Lett. 1987 Jul 27;219(2):360-4.

44.

Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.

Nagase F, Ueda K, Kawashima K, Jamshedur Rahman SM, Isobe K, Yoshida T, Hasegawa Y, Ando K, Iwamoto T, Nagura E, et al.

J Immunol. 1987 Apr 1;138(7):2359-65.

PMID:
2951438
45.

Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.

Yokochi T, Kawashima K, Nakashima I, Nagase F, Isobe K, Nagura E, Yamada K, Miyadai T, Kimura Y.

Cancer Res. 1987 Feb 15;47(4):1006-9.

46.

Establishment of a murine leukemia L1210-specific T-cell clone displaying novel in vivo anti-tumor activity.

Nagase F, Ueda K, Nakashima I, Kawashima K, Isobe K, Nagura E, Yamada K, Yokochi T, Hasegawa Y, Yoshida T, et al.

Int J Cancer. 1986 Dec 15;38(6):907-14.

PMID:
3491792
47.

Augmentation of antibody responses of mice to inhaled protein antigens by simultaneously inhaled bacterial lipopolysaccharides.

Mizoguchi K, Nakashima I, Hasegawa Y, Isobe K, Nagase F, Kawashima K, Shimokata K, Kato N.

Immunobiology. 1986 Oct;173(1):63-71.

PMID:
3542812
48.

Adoptive immunotherapy against a local or widespread tumor of a highly malignant and poorly immunogenic mouse leukemia L1210.

Naguma E, Kawashima K, Nagase F, Nakashima I, Ohno R, Yamada K.

Nihon Ketsueki Gakkai Zasshi. 1986 Sep;49(6):1212-21. No abstract available.

PMID:
3492848
49.

[Planning early social rehabilitation of an apoplexy patient using an ambulation table].

Hasegawa M, Koga S, Okamoto C, Watanabe M, Nagase F.

Kangogaku Zasshi. 1986 May;50(5):523-30. Japanese. No abstract available.

PMID:
3637286
50.

Aberrancy in immunogenicity and cell-surface expression of H-2 antigens on erythrocytes.

Nakashima I, Yoshida T, Yokochi T, Ohashi K, Nagase F, Isobe K, Hasegawa Y, Ando K, Inagi R.

Immunogenetics. 1986;24(1):32-40.

PMID:
3488270

Supplemental Content

Loading ...
Support Center